Sarepta Therapeutics, Inc. (SRPT)
17.55
-1.13
(-6.05%)
USD |
NASDAQ |
May 15, 16:00
17.90
+0.35
(+1.99%)
After-Hours: 20:00
Sarepta Therapeutics Profit Margin (Quarterly) : 45.29% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -1.03% |
| Keros Therapeutics, Inc. | -6.46K% |
| REGENXBIO, Inc. | -1.41K% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Cytokinetics, Inc. | -1.06K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -4.97% |
| Return on Assets | -1.87% |
| Return on Invested Capital | -2.57% |
| Gross Profit Margin (Quarterly) | 83.67% |
| Operating Margin (Quarterly) | 49.05% |
| Return on Net Operating Assets | -3.06% |